Dysfunction in the BDNF/TrkB signaling pathway reduces tyrosine phosphorylation of TrkB receptors in the brain, diminishing BDNF activity and resulting in depression-like symptoms [12,13,14]. Here, NTRK2 is linked to depressive symptom measurement.